This is a real-time PCR machine for detection of RNA expression
Ended Awarded
- Contract number
- 75N91022F00001
- Awardee
-
Bio-Rad Laboratories, Inc. UEI SSHPDYFGN7J9 Part of Bio-Rad Laboratories, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,999
Award facts
- Contract value 100% obligated
- $24,999.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
About this award
Bio-Rad Laboratories, Inc.'s Life Science Group Division was awarded a $25K firm fixed-price Blanket Purchase Agreement (BPA) call by the National Cancer Institute on July 11, 2022, for a real-time polymerase chain reaction (PCR) machine designed for detection of RNA expression. The equipment will be delivered to the National Cancer Institute's facility in Bethesda, Maryland, with an ultimate completion date of July 10, 2023. This contract award was not designated as a small business set-aside, reflecting Bio-Rad's established market position as a large, specialized supplier of advanced laboratory instrumentation to federal agencies.
This BPA call represents a targeted procurement under Bio-Rad's broader relationship with the National Institutes of Health, which maintains a $10 million single-award BPA with the company through December 31, 2025, for biological materials, chemicals, laboratory supplies, and specialized research equipment. The real-time PCR system being procured supports the National Cancer Institute's molecular research capabilities, consistent with Bio-Rad's extensive portfolio of federal contracts supplying sophisticated diagnostic and research instrumentation to health, defense, and civilian agencies across the federal government.
Quick answers
Who was awarded contract 75N91022F00001?
75N91022F00001 was awarded to Bio-Rad Laboratories, Inc. by National Cancer Institute (National Institutes of Health) on July 11, 2022.
How much is contract 75N91022F00001 worth?
The government has obligated $24,999 on 75N91022F00001.
Is contract 75N91022F00001 an order under another contract?
Yes. 75N91022F00001 is a BPA call under HHSN263201500172B, a blanket purchase agreement.
Was contract 75N91022F00001 competed?
The extent of competition for 75N91022F00001 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award